These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7872685)

  • 1. Stability of ras oncogene mutation in the human tumor xenografts through serial passages.
    Kijima H; Abe Y; Yamazaki H; Ohnishi Y; Ueyama Y; Tamaoki N; Nakamura M
    Anticancer Res; 1994; 14(6B):2583-7. PubMed ID: 7872685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Point mutation at codon 12 of c-Ki-ras oncogene in human pancreatic neoplasms and normal human pancreas tissue].
    Cui Q; Wang Z; Chen J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Jun; 16(3):201-5. PubMed ID: 7805165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycine to aspartic acid mutations at codon 13 of the c-Ki-ras gene in human gastrointestinal cancers.
    Nagata Y; Abe M; Kobayashi K; Yoshida K; Ishibashi T; Naoe T; Nakayama E; Shiku H
    Cancer Res; 1990 Feb; 50(3):480-2. PubMed ID: 2404571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orthotopic xenografts of human pancreatic carcinomas acquire genetic aberrations during dissemination in nude mice.
    Reyes G; Villanueva A; García C; Sancho FJ; Piulats J; Lluís F; Capellá G
    Cancer Res; 1996 Dec; 56(24):5713-9. PubMed ID: 8971180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ribozyme against mutant K-ras mRNA suppresses tumor growth of pancreatic cancer.
    Kijima H; Yamazaki H; Nakamura M; Scanlon KJ; Osamura RY; Ueyama Y
    Int J Oncol; 2004 Mar; 24(3):559-64. PubMed ID: 14767540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of point mutations of C-Ki-ras oncogene in colon cancer by PCR using specific oligonucleotide probes].
    Xu KM
    Zhonghua Zhong Liu Za Zhi; 1992 Jul; 14(4):261-3. PubMed ID: 1396073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the Kirsten-ras oncogene are common but lack correlation with prognosis and tumor stage in human pancreatic carcinoma.
    Motojima K; Urano T; Nagata Y; Shiku H; Tsunoda T; Kanematsu T
    Am J Gastroenterol; 1991 Dec; 86(12):1784-8. PubMed ID: 1962623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
    Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
    Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
    Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
    Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features.
    Yamada T; Nakamori S; Ohzato H; Oshima S; Aoki T; Higaki N; Sugimoto K; Akagi K; Fujiwara Y; Nishisho I; Sakon M; Gotoh M; Monden M
    Clin Cancer Res; 1998 Jun; 4(6):1527-32. PubMed ID: 9626473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53, Ki-ras, and DNA ploidy in human pancreatic ductal adenocarcinomas.
    Weyrer K; Feichtinger H; Haun M; Weiss G; Ofner D; Weger AR; Umlauft F; Grünewald K
    Lab Invest; 1996 Jan; 74(1):279-89. PubMed ID: 8569192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Point mutation of K-ras gene in pancreatic carcinoma].
    Huang YT; Yang YM; Liu Q
    Zhonghua Yi Xue Za Zhi; 1994 Feb; 74(2):77-9, 125-6. PubMed ID: 8069725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-radioactive detection of K-ras mutations by nested allele specific PCR and oligonucleotide hybridization.
    Paranavitana CM
    Mol Cell Probes; 1998 Oct; 12(5):309-15. PubMed ID: 9778456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential activation of the c-Ki-ras-2 proto-oncogene in human colorectal carcinoma.
    Halatsch ME; Hirsch-Ernst KI; Weinel RJ; Kahl GF
    Anticancer Res; 1998; 18(4A):2323-5. PubMed ID: 9703874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant point mutation of tumor suppressor gene p53 and oncogene c-N-ras in malignant neuroendocrine pancreatic tumor.
    Hrasćan R; Pavelić K; Pavicić D; Krizanac S; Stajcer-Sittić V; Pecur L; Spaventi S; Klimpfinger M; Pavelić J
    Anticancer Res; 1996; 16(6B):3761-6. PubMed ID: 9042254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ki-ras codon 12 point and P53 mutations: a molecular examination of the main tumor, liver, portal vein, peripheral arterial blood and para-aortic lymph node in pancreatic cancer.
    Yamaguchi K; Chijiiwa K; Torato N; Kinoshita M; Tanaka M
    Am J Gastroenterol; 2000 Aug; 95(8):1939-45. PubMed ID: 10950039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of K-ras codon 12 and 13 mutations found in pancreatic adenocarcinoma of 30 Chinese patients by microdissection, PCR and direct sequencing.
    Wei S; Liang Z; Gao J; Wu S; Zhu H; Liu H; Liu T
    J Gastroenterol Hepatol; 2005 Jan; 20(1):67-72. PubMed ID: 15610449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality.
    Al-Mulla F; Going JJ; Sowden ET; Winter A; Pickford IR; Birnie GD
    J Pathol; 1998 Jun; 185(2):130-8. PubMed ID: 9713338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of point mutation of Kirsten ras oncogene in pancreatic carcinoma by polymerase chain reaction].
    Motojima K; Kohara N; Furui J; Terada M; Tsunoda T; Nagata Y; Urano K
    Nihon Geka Gakkai Zasshi; 1991 Apr; 92(4):453-8. PubMed ID: 1870574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. K-ras activation in neoplasms of the human female reproductive tract.
    Enomoto T; Inoue M; Perantoni AO; Terakawa N; Tanizawa O; Rice JM
    Cancer Res; 1990 Oct; 50(19):6139-45. PubMed ID: 2205377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.